Main This measure shows the number of commercial, research, and emergency INDs / IDEs received in the month. An IND / IDE application is submitted to the FDA to request permission to conduct U.S. clinical trials using investigational products. Commercial INDs / IDEs reflect new products under development. Research INDs / IDEs reflect work that supports research and public health initiatives. Emergency INDs are requests to FDA, generally made by telephone, for an investigational drug to be used for the treatment of an individual patient by a licensed physician. <i>Information is current as of September 30, 2012</i> (1) Tracking against these measures did not start until July 2010 Number column

Jul 2010 8 Aug 2010 13 Sep 2010 10

FY 2011 Total: 99

Oct 2010 7 Nov 2010 10 Dec 2010 8 Jan 2011 10 Feb 2011 8 Mar 2011 5 Apr 2011 12 May 2011 5 Jun 2011 5 Jul 2011 12 Aug 2011 8 Sep 2011 9

FY 2012 Total: 104

Oct 2011 5 Nov 2011 8 Dec 2011 15 Jan 2012 12 Feb 2012 10 Mar 2012 10 Apr 2012 7 May 2012 7 Jun 2012 6 Jul 2012 10 Aug 2012 5 Sep 2012 7 Main Number column

Jul 2010 11 Aug 2010 14 Sep 2010 12

FY 2011 Total: 172

Oct 2010 14 Nov 2010 10 Dec 2010 12 Jan 2011 9 Feb 2011 11 Mar 2011 16 Apr 2011 21 May 2011 11 Jun 2011 10 Jul 2011 16 Aug 2011 15 Sep 2011 27

FY 2012 Total: 187

Oct 2011 20 Nov 2011 16 Dec 2011 13 Jan 2012 13 Feb 2012 13 Mar 2012 10 Apr 2012 17 May 2012 14 Jun 2012 18 Jul 2012 17 Aug 2012 17 Sep 2012 9 Main Number column

Jul 2010 4 Aug 2010 1 Sep 2010 2

FY 2011 Total: 17

Oct 2010 1 Nov 2010 3 Dec 2010 1 Jan 2011 2 Feb 2011 1 Mar 2011 2 Apr 2011 4 May 2011 0 Jun 2011 0 Jul 2011 1 Aug 2011 1 Sep 2011 1

FY 2012 Total: 35

Oct 2011 2 Nov 2011 2 Dec 2011 1 Jan 2012 1 Feb 2012 1 Mar 2012 4 Apr 2012 3 May 2012 3 Jun 2012 5 Jul 2012 3 Aug 2012 3 Sep 2012 5 http://www.fda.gov/AboutFDA/Transparency/track/ucm206804.htm FDA-TRACK CBER Dashboard word text word defintion ਍††਍਍਍਍਍਍਍